Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 450 | 110 | 310 | 80 | 100 |
| Receivables | 2,000 | 2,170 | 1,530 | 840 | 1,540 |
| Other current assets | 270 | 140 | 270 | 30 | 100 |
| TOTAL | $2,720 | $2,420 | $2,110 | $950 | $1,740 |
| Non-Current Assets | |||||
| PPE Net | 50 | 30 | 30 | 180 | 320 |
| Investments And Advances | 0 | 3 | 6 | 6 | 0 |
| Other Non-Current Assets | 9 | 7 | 30 | 130 | 80 |
| TOTAL | $59 | $40 | $66 | $316 | $400 |
| Total Assets | $2,790 | $2,470 | $2,190 | $1,280 | $2,160 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,170 | 1,560 | 1,150 | 470 | 1,020 |
| Accrued Expenses | 440 | 340 | 520 | 340 | 460 |
| Other current liabilities | 210 | 80 | 130 | 130 | 150 |
| TOTAL | $1,830 | $2,330 | $2,620 | $1,350 | $2,240 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 120 | 120 |
| TOTAL | $N/A | $N/A | $N/A | $120 | $120 |
| Total Liabilities | $1,830 | $2,330 | $2,620 | $1,480 | $2,370 |
| Shareholders' Equity | |||||
| Common Shares | 120 | 110 | 110 | 110 | 110 |
| Retained earnings | -12,510 | -13,240 | -13,810 | -13,580 | -13,590 |
| Other shareholders' equity | 130 | 140 | 150 | 150 | 160 |
| TOTAL | $950 | $130 | $-430 | $-200 | $-200 |
| Total Liabilities And Equity | $2,780 | $2,460 | $2,190 | $1,280 | $2,170 |